Pregnancy and adult congenital heart disease

References

• Steer PJ, Gatzoulis MA, Baker ON. Heart Disease and Pregnancy. RCOG, London, UK (2006).
   Google Scholar
• Robson SC, Hunter S, Boys RJ, Dunlop W. Serial study of factors influencing changes in cardiac output during human pregnancy. Am. J. Physiol.256(4 Pt 2), H1060–H1065 (1989).
   PubMed Web of Science ®Google Scholar
• Hunter S, Robson SC. Adaptation of the maternal heart in pregnancy. Br. Heart J.68(6), 540–543 (1992).
   PubMedGoogle Scholar
• Whittaker PG, Macphail S, Lind T. Serial hematologic changes and pregnancy outcome. Obstet. Gynecol.88(1), 33–39 (1996).
   PubMed Web of Science ®Google Scholar
• Mabie WC, DiSessa TG, Crocker LG, Sibai BM, Arheart KL. A longitudinal study of cardiac output in normal human pregnancy. Am. J. Obstet. Gynecol.170(3), 849–856 (1994).
   PubMed Web of Science ®Google Scholar
• Kametas NA, McAuliffe F, Hancock J, Chambers J, Nicolaides KH. Maternal left ventricular mass and diastolic function during pregnancy. Ultrasound Obstet. Gynecol.18(5), 460–466 (2001).
   PubMed Web of Science ®Google Scholar
• Robson SC, Dunlop W, Boys RJ, Hunter S. Cardiac output during labour. Br. Med. J. (Clin. Res. Ed.)295(6607), 1169–1172 (1987).
   PubMed Web of Science ®Google Scholar
• Robson SC, Hunter S, Moore M, Dunlop W. Haemodynamic changes during the puerperium: a Doppler and M-mode echocardiographic study. Br. J. Obstet. Gynaecol.94(11), 1028–1039 (1987).
   PubMedGoogle Scholar
• Capeless EL, Clapp JF. When do cardiovascular parameters return to their preconception values? Am. J. Obstet. Gynecol.165(4 Pt 1), 883–886 (1991).
   PubMed Web of Science ®Google Scholar
• Brenner B. Haemostatic changes in pregnancy. Thromb. Res.114(5–6), 409–414 (2004).
   PubMed Web of Science ®Google Scholar
• Greer IA. Thrombosis in pregnancy: maternal and fetal issues. Lancet353(9160), 1258–1265 (1999).
   PubMed Web of Science ®Google Scholar
• Cerneca F, Ricci G, Simeone R et al. Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Eur. J. Obstet. Gynecol. Reprod. Biol.73(1), 31–36 (1997).
   PubMed Web of Science ®Google Scholar
• Walker MC, Garner PR, Keely EJ, Rock GA, Reis MD. Changes in activated protein C resistance during normal pregnancy. Am. J. Obstet. Gynecol.177(1), 162–169 (1997).
   PubMed Web of Science ®Google Scholar
• Coolman M, de Groot CJ, Steegers EA et al. Concentrations of plasminogen activators and their inhibitors in blood preconceptionally, during and after pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol.128(1–2), 22–28 (2006).
   PubMed Web of Science ®Google Scholar
• Uchikova EH, Ledjev II. Changes in haemostasis during normal pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol.119(2), 185–188 (2005).
   PubMed Web of Science ®Google Scholar
• Ulusoy RE, Demiralp E, Kirilmaz A et al. Aortic elastic properties in young pregnant women. Heart Vessels21(1), 38–41 (2006).
   PubMed Web of Science ®Google Scholar
• Edouard DA, Pannier BM, London GM, Cuche JL, Safar ME. Venous and arterial behavior during normal pregnancy. Am. J. Physiol.274(5 Pt 2), H1605–H1612 (1998).
   PubMed Web of Science ®Google Scholar
• Bernstein IM, Thibault A, Mongeon JA, Badger GJ. The influence of pregnancy on arterial compliance. Obstet. Gynecol.105(3), 621–625 (2005).
   PubMed Web of Science ®Google Scholar
• Menon R, Fortunato SJ. The role of matrix degrading enzymes and apoptosis in rupture of membranes. J. Soc. Gynecol. Investig.11(7), 427–437 (2004).
   PubMedGoogle Scholar
• Khairy P, Ouyang DW, Fernandes SM et al. Pregnancy outcomes in women with congenital heart disease. Circulation113(4), 517–524 (2006).
   PubMed Web of Science ®Google Scholar
• Siu SC, Sermer M, Colman JM et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation104(5), 515–521 (2001).
   PubMed Web of Science ®Google Scholar
• Siu SC, Sermer M, Harrison DA et al. Risk and predictors for pregnancy-related complications in women with heart disease. Circulation96(9), 2789–2794 (1997).
   PubMed Web of Science ®Google Scholar
• Bonow RO, Carabello BA, Kanu C et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation114(5), e84–e231 (2006).
   PubMed Web of Science ®Google Scholar
• Drenthen W, Pieper PG, Roos-Hesselink JW et al. Outcome of pregnancy in women with congenital heart disease: a literature review. J. Am. Coll. Cardiol.49(24), 2303–2311 (2007).
   PubMed Web of Science ®Google Scholar
• Walsh EP, Cecchin F. Arrhythmias in adult patients with congenital heart disease. Circulation115(4), 534–545 (2007).
   PubMed Web of Science ®Google Scholar
• Berlinerblau R, Yessian A, Lichstein E et al. Maternal arrhythmias of normal labor and delivery. Gynecol. Obstet. Invest.52(2), 128–131 (2001).
   PubMed Web of Science ®Google Scholar
• Niwa K, Tateno S, Akagi T et al. Arrhythmia and reduced heart rate variability during pregnancy in women with congenital heart disease and previous reparative surgery. Int. J. Cardiol. (2007) (Epub ahead of print).
   Google Scholar
• Shotan A, Ostrzega E, Mehra A, Johnson JV, Elkayam U. Incidence of arrhythmias in normal pregnancy and relation to palpitations, dizziness, and syncope. Am. J. Cardiol.79(8), 1061–1064 (1997).
   PubMed Web of Science ®Google Scholar
• Silversides CK, Harris L, Haberer K et al. Recurrence rates of arrhythmias during pregnancy in women with previous tachyarrhythmia and impact on fetal and neonatal outcomes. Am. J. Cardiol.97(8), 1206–1212 (2006).
   PubMed Web of Science ®Google Scholar
• Elvan-Taspinar A, Franx A, Bots ML, Bruinse HW, Koomans HA. Central hemodynamics of hypertensive disorders in pregnancy. Am. J. Hypertens.17(10), 941–946 (2004).
   PubMed Web of Science ®Google Scholar
• Aardenburg R, Spaanderman ME, van Eijndhoven HW, de Leeuw PW, Peeters LL. A low plasma volume in formerly preeclamptic women predisposes to the recurrence of hypertensive complications in the next pregnancy. J. Soc. Gynecol. Investig.13(8), 598–603 (2006).
   PubMedGoogle Scholar
• Lampinen KH, Ronnback M, Kaaja RJ, Groop PH. Impaired vascular dilatation in women with a history of pre-eclampsia. J. Hypertens.24(4), 751–756 (2006).
   PubMed Web of Science ®Google Scholar
• Duvekot JJ, Cheriex EC, Pieters FA et al. Maternal volume homeostasis in early pregnancy in relation to fetal growth restriction. Obstet. Gynecol.85(3), 361–367 (1995).
   PubMed Web of Science ®Google Scholar
• Espinoza J, Romero R, Nien JK et al. Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor. Am. J. Obstet. Gynecol.196(4), 326.e321–326.e313 (2007).
   Google Scholar
• Myers JE, Hart S, Armstrong S et al. Evidence for multiple circulating factors in preeclampsia. Am. J. Obstet. Gynecol.196(3), e261–e266 (2007).
   PubMed Web of Science ®Google Scholar
• Harrington K, Goldfrad C, Carpenter RG, Campbell S. Transvaginal uterine and umbilical artery Doppler examination of 12–16 weeks and the subsequent development of pre-eclampsia and intrauterine growth retardation. Ultrasound Obstet. Gynecol.9(2), 94–100 (1997).
   PubMed Web of Science ®Google Scholar
• Bamfo JE, Kametas NA, Turan O, Khaw A, Nicolaides KH. Maternal cardiac function in fetal growth restriction. BJOG113(7), 784–791 (2006).
   PubMed Web of Science ®Google Scholar
• Aardema MW, Oosterhof H, Timmer A, van Rooy I, Aarnoudse JG. Uterine artery Doppler flow and uteroplacental vascular pathology in normal pregnancies and pregnancies complicated by pre-eclampsia and small for gestational age fetuses. Placenta22(5), 405–411 (2001).
   PubMed Web of Science ®Google Scholar
• Papageorghiou AT, Roberts N. Uterine artery Doppler screening for adverse pregnancy outcome. Curr. Opin. Obstet. Gynecol.17(6), 584–590 (2005).
   PubMed Web of Science ®Google Scholar
• Burn J, Brennan P, Little J et al. Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet351(9099), 311–316 (1998).
   PubMed Web of Science ®Google Scholar
• Gill HK, Splitt M, Sharland GK, Simpson JM. Patterns of recurrence of congenital heart disease: an analysis of 6640 consecutive pregnancies evaluated by detailed fetal echocardiography. J. Am. Coll. Cardiol.42(5), 923–929 (2003).
   PubMed Web of Science ®Google Scholar
• Caputo S, Capozzi G, Russo MG et al. Familial recurrence of congenital heart disease in patients with ostium secundum atrial septal defect. Eur. Heart J.26(20), 2179–2184 (2005).
   PubMed Web of Science ®Google Scholar
• Presbitero P, Boccuzzi GG, de Groot CJM, Roos-Hesselink JW. Pregnancy and heart disease. In: The ESC Textbook of Cardiovascular Medicine. Camm AJ, Lüscher TF, Serruys PW (Eds.) Blackwell publishing, Oxford, UK 607–624 (2006).
   Google Scholar
• Presbitero P, Somerville J, Stone S et al. Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus. Circulation89(6), 2673–2676 (1994).
   PubMed Web of Science ®Google Scholar
• Avila WS, Grinberg M, Snitcowsky R et al. Maternal and fetal outcome in pregnant women with Eisenmenger’s syndrome. Eur. Heart J.16(4), 460–464 (1995).
   PubMed Web of Science ®Google Scholar
• European Society of Cardiology. Expert consensus document on management of cardiovascular diseases during pregnancy. Eur. Heart J.24(8), 761–781 (2003).
   PubMed Web of Science ®Google Scholar
• Veldtman GR, Connolly HM, Grogan M, Ammash NM, Warnes CA. Outcomes of pregnancy in women with tetralogy of Fallot. J. Am. Coll. Cardiol.44(1), 174–180 (2004).
   PubMed Web of Science ®Google Scholar
• Drenthen W, Pieper PG, van der Tuuk K et al. Cardiac complications relating to pregnancy and recurrence of disease in the offspring of women with atrioventricular septal defects. Eur. Heart. J.26(23), 2581–2587 (2005).
   PubMed Web of Science ®Google Scholar
• Guedes A, Mercier LA, Leduc L et al. Impact of pregnancy on the systemic right ventricle after a Mustard operation for transposition of the great arteries. J. Am. Coll. Cardiol.44(2), 433–437 (2004).
   PubMed Web of Science ®Google Scholar
• Drenthen W, Pieper PG, Ploeg M et al. Risk of complications during pregnancy after Senning or Mustard (atrial) repair of complete transposition of the great arteries. Eur. Heart J.26(23), 2588–2595 (2005).
   PubMed Web of Science ®Google Scholar
• Clarkson PM, Wilson NJ, Neutze JM et al. Outcome of pregnancy after the Mustard operation for transposition of the great arteries with intact ventricular septum. J. Am. Coll. Cardiol.24(1), 190–193 (1994).
   PubMed Web of Science ®Google Scholar
• Ploeg M, Drenthen W, van Dijk A, Pieper PG. Successful pregnancy after an arterial switch procedure for complete transposition of the great arteries. Br. J. Obstet. Gynaecol.113(2), 243–244 (2006).
   Google Scholar
• Connolly HM, Grogan M, Warnes CA. Pregnancy among women with congenitally corrected transposition of great arteries. J. Am. Coll. Cardiol.33(6), 1692–1695 (1999).
   PubMed Web of Science ®Google Scholar
• Hameed A, Karaalp IS, Tummala PP et al. The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J. Am. Coll. Cardiol.37(3), 893–899 (2001).
   PubMed Web of Science ®Google Scholar
• Lesniak-Sobelga A, Tracz W, KostKiewicz M, Podolec P, Pasowicz M. Clinical and echocardiographic assessment of pregnant women with valvular heart diseases--maternal and fetal outcome. Int. J. Cardiol.94(1), 15–23 (2004).
   PubMed Web of Science ®Google Scholar
• Silversides CK, Colman JM, Sermer M, Farine D, Siu SC. Early and intermediate-term outcomes of pregnancy with congenital aortic stenosis. Am. J. Cardiol.91(11), 1386–1389 (2003).
   PubMed Web of Science ®Google Scholar
• Drenthen W, Pieper PG, Roos-Hesselink JW et al. Non-cardiac complications during pregnancy in women with isolated congenital pulmonary valvar stenosis. Heart92(12), 1838–1843 (2006).
   PubMed Web of Science ®Google Scholar
• Meijboom LJ, Drenthen W, Pieper PG et al. Obstetric complications in Marfan syndrome. Int. J. Cardiol.110(1), 53–59 (2006).
   PubMed Web of Science ®Google Scholar
• Beauchesne LM, Connolly HM, Ammash NM, Warnes CA. Coarctation of the aorta: outcome of pregnancy. J. Am. Coll. Cardiol.38(6), 1728–1733 (2001).
   PubMed Web of Science ®Google Scholar
• Elkayam U, Bitar F. Valvular heart disease and pregnancy: part II: prosthetic valves. J. Am. Coll. Cardiol.46(3), 403–410 (2005).
   PubMed Web of Science ®Google Scholar
• El SF, Hassan W, Latroche B et al. Pregnancy has no effect on the rate of structural deterioration of bioprosthetic valves: long-term 18-year follow up results. J. Heart Valve Dis.14(4), 481–485 (2005).
   PubMed Web of Science ®Google Scholar
• Mihaljevic T, Paul S, Leacche M et al. Valve replacement in women of childbearing age: influences on mother, fetus and neonate. J. Heart Valve Dis.14(2), 151–157 (2005).
   PubMed Web of Science ®Google Scholar
• Sadler L, McCowan L, White H et al. Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves. Br.J. Obstet. Gynaecol.107(2), 245–253 (2000).
   Google Scholar
• CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet343(8898), 619–629 (1994).
   PubMed Web of Science ®Google Scholar
• Elkayam U, Singh H, Irani A, Akhter MW. Anticoagulation in pregnant women with prosthetic heart valves. J. Cardiovasc. Pharmacol. Ther.9(2), 107–115 (2004).
   PubMed Web of Science ®Google Scholar
• James AH, Brancazio LR, Gehrig TR, Wang A, Ortel TL. Low-molecular-weight heparin for thromboprophylaxis in pregnant women with mechanical heart valves. J. Matern. Fetal Neonatal Med.19(9), 543–549 (2006).
   PubMed Web of Science ®Google Scholar
• Hirsh J, Fuster V, Ansell J, Halperin JL. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. J. Am. Coll. Cardiol.41(9), 1633–1652 (2003).
   PubMed Web of Science ®Google Scholar
• Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch. Intern. Med.160(2), 191–196 (2000).
   PubMedGoogle Scholar
• Vitale N, De Feo M, De Santo LS et al. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J. Am. Coll. Cardiol.33(6), 1637–1641 (1999).
   PubMed Web of Science ®Google Scholar
• Bates SM, Greer IA, Hirsh J, Ginsberg JS. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest126(Suppl. 3), S627–S644 (2004).
   PubMed Web of Science ®Google Scholar
• Roos-Hesselink JW, Meijboom FJ, Leebeek FW, de Groot CJ. Pregnancy and the mechanical prosthetic valve: dilemmas about the choice of antithrombotic prophylaxis. Ned. Tijdschr. Geneeskd.151(7), 389–394 (2007).
   PubMedGoogle Scholar
• Montan S. Drugs used in hypertensive diseases in pregnancy. Curr. Opin. Obstet. Gynecol.16(2), 111–115 (2004).
   PubMed Web of Science ®Google Scholar
• Cooper WO, Hernandez-Diaz S, Arbogast PG et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N. Engl. J. Med.354(23), 2443–2451 (2006).
   PubMed Web of Science ®Google Scholar
• Alwan S, Polifka JE, Friedman JM. Angiotensin II receptor antagonist treatment during pregnancy. Birth Defects Res. Part A Clin. Mol. Teratol.73(2), 123–130 (2005).
   PubMed Web of Science ®Google Scholar
• Vigil-De Gracia P, Lasso M, Ruiz E et al. Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial. Eur. J. Obstet. Gynecol. Reprod. Biol.128(1–2), 157–162 (2006).
   PubMed Web of Science ®Google Scholar
• Joglar JA, Page RL. Antiarrhythmic drugs in pregnancy. Curr. Opin. Cardiol.16(1), 40–45 (2001).
   PubMed Web of Science ®Google Scholar
• Ferrero S, Colombo BM, Ragni N. Maternal arrhythmias during pregnancy. Arch. Gynecol. Obstet.269(4), 244–253 (2004).
   PubMedGoogle Scholar
• Trappe HJ. Acute therapy of maternal and fetal arrhythmias during pregnancy. J. Intensive Care Med.21(5), 305–315 (2006).
   PubMedGoogle Scholar
• Damilakis J, Theocharopoulos N, Perisinakis K et al. Conceptus radiation dose and risk from cardiac catheter ablation procedures. Circulation104(8), 893–897 (2001).
   PubMed Web of Science ®Google Scholar
• Esteves CA, Munoz JS, Braga S et al. Immediate and long-term follow-up of percutaneous balloon mitral valvuloplasty in pregnant patients with rheumatic mitral stenosis. Am. J. Cardiol.98(6), 812–816 (2006).
   PubMed Web of Science ®Google Scholar
• Yap SC, de Jaegere PP, Ligthart JM, Serruys PW, Roos-Hesselink JW. Percutaneous triple-valve balloon valvulotomy in a pregnant woman using intracardiac echocardiography: case report. J. Heart Valve Dis.15(3), 459–464 (2006).
   PubMed Web of Science ®Google Scholar
• Arnoni RT, Arnoni AS, Bonini RC et al. Risk factors associated with cardiac surgery during pregnancy. Ann. Thorac. Surg.76(5), 1605–1608 (2003).
   PubMed Web of Science ®Google Scholar